Integra LifeSciences Corporation (IART) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Integra LifeSciences Cor...

    NASDAQ: IART · Real-Time Price · USD
    15.46
    -0.53 (-3.31%)
    At close: Sep 08, 2025, 2:52 PM

    Integra LifeSciences Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 246.38M 276.4M 456.66M 513.45M
    Short-Term Investments
    		 27.19M 32.69M 16.68M n/a
    Long-Term Investments
    		 n/a 30.71M 567.34M 6.48M
    Other Long-Term Assets
    		 66.52M 27.48M -510.15M 9.96M
    Receivables
    		 272.37M 259.33M 263.46M 231.83M
    Inventory
    		 429.09M 389.61M 324.58M 317.39M
    Other Current Assets
    		 29.65M 32.64M 31.03M n/a
    Total Current Assets
    		 1.08B 1.06B 1.16B 1.15B
    Property-Plant & Equipment
    		 549.76M 496.38M 459.59M 396.25M
    Goodwill & Intangibles
    		 2.3B 2.12B 2.17B 2.16B
    Total Long-Term Assets
    		 2.96B 2.72B 2.73B 2.63B
    Total Assets
    		 4.04B 3.78B 3.89B 3.78B
    Account Payables
    		 82.5M 92.33M 102.1M 61.84M
    Deferred Revenue
    		 n/a 8.54M 7.25M 5.29M
    Short-Term Debt
    		 607.08M 14.53M 52.75M 59.77M
    Other Current Liabilities
    		 232.55M 100.84M 65.41M 105.68M
    Total Current Liabilities
    		 922.13M 306.98M 320.91M 340.02M
    Long-Term Debt
    		 1.2B 1.49B 1.41B 1.5B
    Other Long-Term Liabilities
    		 313.17M 192.24M 138.5M 120.26M
    Total Long-Term Liabilities
    		 1.57B 1.89B 1.76B 1.76B
    Total Liabilities
    		 2.49B 2.19B 2.09B 2.1B
    Total Debt
    		 1.98B 1.68B 1.62B 1.65B
    Common Stock
    		 916K 909K 905K 896K
    Retained Earnings
    		 939.91M 946.86M 879.12M 698.57M
    Comprehensive Income
    		 -27.57M -15.11M 10.27M -45.16M
    Shareholders Equity
    		 1.55B 1.59B 1.8B 1.68B
    Total Investments
    		 27.19M 64.87M 567.34M 6.48M

    Add to Watchlist